Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter 2025 results on April 29, 2025. The ...

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to ...

GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the ...

Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25Completed SAD/MAD dosing in KT-621 Phase 1 ...

Medicare Part D may typically cover most outpatient prescription medications. These include antibiotics like azithromycin. Learn more here.

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) for the treatment of chronic spontaneous ...

AbsoluteCare®, a value-based health care company, and CareSource Ohio are expanding their partnership to bring whole-person care to dual-eligible MyCare members who qualify for both Medicare and ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Ligand Pharmaceuticals offers biotech exposure with reduced risk through its royalty platform. Discover why its valuation now ...

The Strategy outperformed its benchmark as strong stock selection in health care and consumer discretionary sectors overcame ...